AppSwarm Launches AskOptima.com to Advance AI-Powered Search Technology
TULSA, OKLAHOMA - May 7, 2025 (NEWMEDIAWIRE) - AppSwarm, Corp. (OTC: SWRM), a collective of creative and technological minds focused on gaming app development, business app development, web development, and white-label technology solutions, is proud to announce its launch of AskOptima.com, an AI-powered search engine platform that leverages the latest advancements in artificial intelligence. This strategic move not only expands AppSwarm's technological portfolio but also enhances its commitment to delivering sophisticated tools designed to optimize user engagement and search accuracy.
AskOptima
AskOptima.com is more than just a search engine - it's a complete, flexible solution tailored to modern digital needs:
Memorable & SEO-Friendly: The domain name is easy to remember, which should allow for repeat visits. With valuable keywords like "Ask" and "Optima" the name could enhance visibility and search engine ranking. Additionally, its prestigious .com extension reinforces credibility and professionalism.
Contextual Understanding: Advanced NLP enables the platform to comprehend nuanced queries, delivering results that align with user intent rather than simple keyword matches.
Real-Time Data Integration: AskOptima.com pulls live web data to provide current and reliable answers.
Conversational Search: Users can engage in iterative dialogues, asking follow-up questions with context carried over, mimicking natural human interaction.
Scalable Architecture: Built for low latency and high throughput, the platform supports enterprise-level applications, from e-commerce to research and analytics.
Enhanced Search Capabilities & Engagement:
AskOptima allows customers to gain full control over their search functionality and tailor it to meet their specific needs.
AskOptima delivers highly relevant results that enhance user satisfaction and engagement keeping visitors on site longer with a seamless, effective search experience.
"We believe that innovative search technology builds the backbone of digital engagement," said Christopher Bailey, [CEO] at AppSwarm. "Producing AskOptima.com not only provides us with a robust, premium domain, but also empowers AppSwarm to compete in the AI realm delivering a search experience that is both intuitive and transformative. Currently in the form of a web app, we are in the process of converting AskOptima to be available on iOS and Android moving forward."
The production of AskOptima.com is a key step in AppSwarm's ongoing commitment to embrace state-of-the-art technology solutions that can set new benchmarks in user engagement and service delivery. With AskOptima.com, customers can now harness an advanced, AI-powered tool that marries premium branding with dynamic functionality.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Ethical Web AI Launches AI Vault SaaS on AWS Marketplace
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Bubblr Inc., doing business as Ethical Web AI (OTC: BBLR), a leader in enterprise-specific generative AI, is proud to announce the launch of AI Vault SaaS on the AWS Marketplace. This new software-as-a-service version of AI Vault marks a major milestone for the company, dramatically simplifying deployment and expanding market accessibility. AI Vault Enterprise—Ethical Web AI's original flagship solution—requires integration into a client's AWS environment, often involving time and DevOps resources. While larger enterprises may accommodate this with ease, smaller companies and those seeking to trial the product may find it a barrier to adoption. The new AI Vault SaaS eliminates this friction. Now available directly via the AWS Marketplace, it allows businesses to deploy instantly without needing to configure their cloud infrastructure. This significantly shortens the sales cycle and makes it easy for companies of all sizes to experience AI Vault's capabilities firsthand. 'The launch of AI Vault SaaS is a game-changer,' said Steve Morris, CTO and Founder of Ethical Web AI. 'Amazon's support has been phenomenal throughout this process. Our recent accreditation as an AWS Software Partner has been one of the most significant milestones in our history. It's enabled us to deliver both versions of AI Vault through the AWS Marketplace and unlock powerful co-marketing opportunities.' AI Vault SaaS is priced at $20 per user, slightly higher than the $15 per user cost of AI Vault Enterprise due to Ethical Web AI absorbing the full computational workload. Despite this, both offerings remain more cost-effective than typical generative AI competitors, offering significantly greater enterprise control and transparency. The company expects to onboard its first five clients within the next week, a milestone that will activate expanded AWS co-marketing support and signal the start of a full-scale commercial push through direct sales and reseller partnerships. About AI VaultAI Vault is a groundbreaking generative AI platform engineered for enterprises that prioritise security, privacy, and control. With 27% of global businesses—especially financial institutions and highly regulated organisations—hesitant to adopt generative AI due to data concerns, AI Vault provides a trusted alternative. The platform offers: Full control and visibility over AI interactions within the organisation Zero data sharing with Ethical Web AI or any third-party LLM partners Protection through three USPTO patents, including a key patent that guarantees client data never leaves their environment Watch the explainer video to see AI Vault in action: AI Vault Explainer Video ( About Ethical Web AIEthical Web AI is a mission-driven technology company advocating for a safer, more transparent internet. Our patented generative AI solutions are designed to empower enterprises with the tools they need to innovate confidently—without compromising ethics, privacy, or security. Safe Harbor StatementThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management. They are subject to several uncertainties and risks that could significantly affect the Company's current plans and expectations, future operations, and financial condition. The Company reserves the right to update or alter its forward-looking statements, whether due to new information, future events or otherwise. Media and investor contact:
Business Wire
3 hours ago
- Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
LAVAL, Quebec--(BUSINESS WIRE)--Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) ('Crescita' or the 'Company'), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results from its Annual General and Special Meeting of Shareholders held at its corporate headquarters in Laval, Quebec on June 4, 2025. The detailed results of the votes received by proxy are as follows: Election of Directors Director Nominees NUMBER OF SHARES PERCENTAGE OF VOTES CAST FOR WITHHELD FOR WITHHELD Daniel N. Chicoine 5,432,232 301,172 94.75% 5.25% Anthony E. Dobranowski 5,455,219 278,185 95.15% 4.85% John C. London 5,427,266 306,138 94.66% 5.34% Deborah Shannon-Trudeau 5,463,225 270,179 95.29% 4.71% Serge Verreault 5,490,982 242,422 95.77% 4.23% Expand Reappointment of External Auditors Outcome NUMBER OF SHARES PERCENTAGE OF VOTES CAST FOR WITHHELD FOR WITHHELD Ernst & Young LLP reappointed 6,388,758 49,767 99.23% 0.77% Expand Approval of the Continuation of Crescita's Shareholder Rights Plan Outcome NUMBER OF SHARES PERCENTAGE OF VOTES CAST FOR AGAINST FOR AGAINST Shareholder Rights Plan approved 5,481,368 252,036 95.60% 4.40% Expand About Crescita Therapeutics Inc. Crescita (TSX: CTX and OTC US: CRRTF) is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities. The Company offers a portfolio of high-quality, science-based non-prescription skincare products and a commercial stage prescription product. We also own multiple proprietary transdermal delivery platforms that support the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. For more information visit, Source: Crescita Therapeutics
Yahoo
13 hours ago
- Yahoo
BYD Just Added Another Problem to Tesla's Long List
There is a heated price war in China's EV market. BYD just unleashed a new round of intense price cuts. Tesla has problems outside of China, too, such as Europe. These 10 stocks could mint the next wave of millionaires › Tesla (NASDAQ: TSLA) investors have been on a bit of a roller coaster ride so far in 2025. The technology company's stock was up early in the year before falling as much as 45% in March and April, and then partially recovering so that it now trades down about 15% for the year. It still trades nearly 28% below all-time highs reached in December 2024. Along the way, there have been constant challenges, including a price war in China, severely declining sales in Europe, and brand backlash related to CEO Elon Musk's involvement in national and international politics. The coaster ride could potentially turn downhill again this month, thanks to China-based electric vehicle (EV) maker BYD's (OTC: BYDDY) recent move to slash prices. The action will apply more pressure to a now-challenging Chinese market that Tesla used to dominate. Let's dig into the details. China's EV market is in the midst of a highly contested battle for market share that includes a brutal price war brought on by multiple factors, including government subsidies, a long list of competing products, and a slowing global economy. These dynamics likely prompted BYD's big move late last month to make vehicle price cuts of as much as 34% on 22 electric and plug-in hybrid vehicle models (effective through the end of June). The announced cuts came after BYD reported its slowest year-over-year sales growth (up 21% in April) in more than four years. BYD's price cuts are likely to force its competitors to enlarge discounts to avoid giving up sales and market share. According to Bloomberg Intelligence, the average vehicle discount in China is around 15% so far this year, but analysts warn it could get even worse during the second half of the year. Even one of Tesla's biggest supporters, Morgan Stanley's Adam Jonas, expressed skepticism that Tesla could catch the competition in China. Jonas suggested Tesla's future is now even more tied to its upcoming launch of a robotaxi service on June 12. A report in the industry website InsideEVs quoted the Morgan Stanley analysis, which summed things up by saying, "We recommend investors have a look at the pictures and specs of the Xiaomi YU7, which looks like a Ferrari or Aston Martin SUV at the price of a Toyota Camry. Then ask yourself if Tesla would be better off introducing more steering-wheel-having EVs." BYD's price cuts add to Tesla's problems overseas. The eventuality of Chinese automakers setting sail for the U.S. market will increase EV competition significantly and exacerbate the issue. Tesla's challenges extend beyond the brutal price war in China. The company has been watching sales plunge in Europe, where the company also once dominated. Tesla's new car registrations in Europe plunged to 7,261 units in April, a decline of 49% over the previous April, according to the European Automobile Manufacturers Association. Through April, Tesla sold roughly 61,000 vehicles in Europe, a 39% decline compared to the same period last year. The automaker's results overseas are certainly weighing on its global sales, which were down 13% during the first quarter -- the worst quarterly decline in the company's history. Tesla has definitely faced adversity in 2025, but there is a little bit of good news for investors. In a recent post on X (formerly Twitter), Musk said he's back to spending 24/7 at work and sleeping in Tesla's conference, server, or factory rooms. Hopefully, with Musk returning his focus to the automotive business, the brand backlash related to his extracurricular activities will eventually blow over. For Tesla, that can't come soon enough. Despite the potential buying opportunity here while the stock is down -- and if you truly believe in Tesla long-term, it is an opportunity -- it might be wise to watch Tesla from the sidelines for the time being. If you're already a shareholder, there's no reason to sell. But know that, right now, the company seems to be facing an identity crisis: is it a robotaxi company, a car manufacturer, or a developer of AI and robotics? It might be wise to wait to invest in Tesla until its strategy forward is more certain. Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this. On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves: Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $356,261!* Apple: if you invested $1,000 when we doubled down in 2008, you'd have $38,291!* Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $657,385!* Right now, we're issuing 'Double Down' alerts for three incredible companies, available when you join , and there may not be another chance like this anytime soon.*Stock Advisor returns as of June 2, 2025 Daniel Miller has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tesla. The Motley Fool recommends BYD Company. The Motley Fool has a disclosure policy. BYD Just Added Another Problem to Tesla's Long List was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
